News

NRC and Glysantis join forces to test innovative nano-material

Partners evaluating nano-particle NanoGlys™ as vaccine adjuvant and drug delivery vehicle January 14, 2016 – Ottawa, ON Guelph-based Glysantis Inc. and Canada’s “go-to” research and technology organization are investigating the potential of the NanoGlys™ nano-particle for biomedical applications. The up-and-coming Canadian life science company is taking advantage of the National Research Council of Canada’s (NRC)… Read more NRC and Glysantis join forces to test innovative nano-material